HIV p24 Antigen Capture Kits

The ACVP at the Frederick National Laboratory (FNL), operated by Leidos Biomedical Research, Inc. (LBR), is supported by NCI Contract 75N91019D00024 from the National Institutes of Health (NIH). To fulfill FNL’s mission of supporting biomedical research, the ACVP is able to provide the HIV-1 p24 antigen capture kit reagents to the University of Pittsburgh via Material Transfer Agreement (MTA).

The process as required by ACVP, FNL, LBR and the University is as follows:

  • The University requesting department emails Terra Ireland ACVP, FNL, LBR, stating the quantity and item(s) required.
  • If this is a new user request, Mrs. Ireland requests detailed customer contact information and then initiates the MTA and within seven (7) business days, emails it to the requesting department for signature.
  • The requesting department must obtain the proper University authorized official signatures on the MTA from the Office of Sponsored Programs (OSP) and should follow the process for an Incoming Material Transfer Agreement.
    • Please note: The length of time for OSP to process the MTA will depend upon the item being purchased, the University researcher’s intended use of the item, the requesting department and possibly any requirements of the grant or contract that is funding the research project.
  • After obtaining the signed MTA from the OSP, the requesting department should email and provide to Mrs. Ireland the following:
    • A FedEx or UPS courier account number (this number must be provided in order to directly charge shipping as LBR no longer invoices the University);
    • The fully executed MTA.
  • Mrs. Ireland then ships the requested items via the requested Shipping Account Number. Once an MTA is established, the researcher only needs to contact Mrs. Ireland for additional reagents. The reagents are provided free of cost; the researcher only needs to provide shipping information to receive them.

Any questions regarding ACVP, FNL, LBR requirements can be addressed to:

Terra Schaden-Ireland MA, MBA  

Research Associate III

Frederick National Laboratory for Cancer Research (FNL)

AIDS and Cancer Virus Program

Leidos Biomedical Research, Inc.

PO Box B

Bldg 535 Rm 535

Frederick, MD 21702

301-846-1790

Terra.Schaden-Ireland@fnlcr.nih.gov